Towards Steroid-Free Immunosuppression after Liver Transplantation
| Published in: | Gut and Liver |
|---|---|
| Main Authors: | Victor M. Zaydfudim, Shawn J. Pelletier |
| Format: | Article |
| Language: | English |
| Published: |
Gastroenterology Council for Gut and Liver
2016-07-01
|
| Online Access: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl16204 |
Similar Items
Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
by: Tonghai Xing, et al.
Published: (2013-01-01)
by: Tonghai Xing, et al.
Published: (2013-01-01)
Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma
by: Qiang Wei, et al.
Published: (2016-07-01)
by: Qiang Wei, et al.
Published: (2016-07-01)
Effectiveness of steroid-free immunosuppressive regimens after kidney transplantation: the pioneering experience of a brazilian center
by: Tainá Veras de Sandes-Freitas, et al.
Published: (2025-09-01)
by: Tainá Veras de Sandes-Freitas, et al.
Published: (2025-09-01)
Immunosuppression and Liver Transplantation
by: Jan Lerut, et al.
Published: (2023-02-01)
by: Jan Lerut, et al.
Published: (2023-02-01)
Side Effects of Immunosuppressant Drugs After Liver Transplant
by: Filippo Gabrielli, et al.
Published: (2025-02-01)
by: Filippo Gabrielli, et al.
Published: (2025-02-01)
The role of immunotolerance in immunosuppressive therapy after liver transplantation
by: E. Yu. Anosova, et al.
Published: (2024-09-01)
by: E. Yu. Anosova, et al.
Published: (2024-09-01)
Tolerance and minimization of immunosuppressive therapy after liver transplantation
by: O. A. Gerasimova, et al.
Published: (2021-09-01)
by: O. A. Gerasimova, et al.
Published: (2021-09-01)
Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study
by: A. Thierry, et al.
Published: (2014-01-01)
by: A. Thierry, et al.
Published: (2014-01-01)
Steroid Avoidance in Liver Transplantation
by: José Oberholzer, et al.
Published: (2004-01-01)
by: José Oberholzer, et al.
Published: (2004-01-01)
Retrospective analysis of immunosuppression drug withdrawal after liver transplantation
by: QI Debin, CHEN Peng, TONG Hui, PENG Chenghong, LI Tao
Published: (2021-05-01)
by: QI Debin, CHEN Peng, TONG Hui, PENG Chenghong, LI Tao
Published: (2021-05-01)
Role of immunosuppression in liver transplantation. Advantages and disadvantages
by: D. Aguirre-Villarreal, et al.
Published: (2025-07-01)
by: D. Aguirre-Villarreal, et al.
Published: (2025-07-01)
Diffusion MRI Findings in Encephalopathy Induced by Immunosuppressive Therapy after Liver Transplantation
by: Emanuele Tinelli, et al.
Published: (2020-01-01)
by: Emanuele Tinelli, et al.
Published: (2020-01-01)
Severe cytomegalovirus infection and immunosuppressive therapy in pediatric liver transplantation
by: E Pehlivanoğlu, et al.
Published: (1990-01-01)
by: E Pehlivanoğlu, et al.
Published: (1990-01-01)
Steroid Avoidance After Adult Living Donor Liver Transplant: A Cohort Analysis
by: Miguel Nunez, BS, et al.
Published: (2023-06-01)
by: Miguel Nunez, BS, et al.
Published: (2023-06-01)
A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT
by: Lorf Thomas, et al.
Published: (2010-04-01)
by: Lorf Thomas, et al.
Published: (2010-04-01)
Use of Methylene Blue for Treatment of Severe Sepsis in an Immunosuppressed Patient after Liver Transplantation
by: Saravanan Ramamoorthy, et al.
Published: (2013-01-01)
by: Saravanan Ramamoorthy, et al.
Published: (2013-01-01)
A Comprehensive Review of Immunosuppression Used for Liver Transplantation
by: Sandeep Mukherjee, et al.
Published: (2009-01-01)
by: Sandeep Mukherjee, et al.
Published: (2009-01-01)
Graft-derived cell-free DNA as a rejection biomarker and a monitoring tool for immunosuppression in liver transplantation
by: V U Lakshmi, et al.
Published: (2023-01-01)
by: V U Lakshmi, et al.
Published: (2023-01-01)
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)
Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation
by: Klara M. Posfay-Barbe, et al.
Published: (2019-12-01)
by: Klara M. Posfay-Barbe, et al.
Published: (2019-12-01)
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant.
by: Gorden Muduma, et al.
Published: (2016-01-01)
by: Gorden Muduma, et al.
Published: (2016-01-01)
Clinical laboratory aspects of one-component immunosuppression during liver transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)
Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient
by: Hiroshi Tamura, et al.
Published: (2021-05-01)
by: Hiroshi Tamura, et al.
Published: (2021-05-01)
ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
by: Mohammad Shagrani, MD, et al.
Published: (2022-12-01)
by: Mohammad Shagrani, MD, et al.
Published: (2022-12-01)
Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation center
by: Sang-Hyun Kang, et al.
Published: (2019-12-01)
by: Sang-Hyun Kang, et al.
Published: (2019-12-01)
Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis Under Immunosuppression After Liver Transplantation
by: Franz Felix Konen, et al.
Published: (2019-09-01)
by: Franz Felix Konen, et al.
Published: (2019-09-01)
THE MODERN IMMUNOSUPPRESSIVE TACTICS AS A WAY FOR INDUCING OF TOLEROGENIC STRATEGY AFTER LIVER TRANSPLANTATION (ANALYSIS OF THE PROBLEM STATUS)
by: S. D. Artamonov, et al.
Published: (2012-05-01)
by: S. D. Artamonov, et al.
Published: (2012-05-01)
The basic principles of immunosuppressive therapy after kidney transplantation
by: D. N. Suslov
Published: (2018-03-01)
by: D. N. Suslov
Published: (2018-03-01)
Adverse effects of immunosuppressive therapy after kidney transplant
by: S. V. Popov, et al.
Published: (2025-03-01)
by: S. V. Popov, et al.
Published: (2025-03-01)
THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION
by: N. N. Koloskova, et al.
Published: (2018-04-01)
by: N. N. Koloskova, et al.
Published: (2018-04-01)
Interest in Immunosuppression Withdrawal among Liver Transplant and Autoimmune Hepatitis Patients
by: Eden Sharabi, et al.
Published: (2021-04-01)
by: Eden Sharabi, et al.
Published: (2021-04-01)
Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
by: Marit S. van Sandwijk, MD, et al.
Published: (2018-06-01)
by: Marit S. van Sandwijk, MD, et al.
Published: (2018-06-01)
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study
by: Finocchietti M, et al.
Published: (2024-01-01)
by: Finocchietti M, et al.
Published: (2024-01-01)
P819: TRANSPLANT, TREATMENT AND TRANSFUSION FREE (TTT-FREE) SURVIVAL AS RELEVANT CLINICAL ENDPOINT AFTER IMMUNOSUPPRESSIVE TREATMENT FOR ACQUIRED APLASTIC ANEMIA IN ADULTS
by: E. Koster, et al.
Published: (2022-06-01)
by: E. Koster, et al.
Published: (2022-06-01)
A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine
by: A. V. Shabunin, et al.
Published: (2021-06-01)
by: A. V. Shabunin, et al.
Published: (2021-06-01)
Immunosuppression and the Immune Response to Transplantation
by: David Ludwin, et al.
Published: (1993-01-01)
by: David Ludwin, et al.
Published: (1993-01-01)
SELF-REPORTED QUALITY OF LIFE, IMPULSIVITY AND NON-ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATION AFTER LIVER TRANSPLANTATION: A COHORT STUDY
by: Ana Paula JESUS-NUNES, et al.
Published: (2025-09-01)
by: Ana Paula JESUS-NUNES, et al.
Published: (2025-09-01)
Changes in Sepsis Biomarkers after Immunosuppressant Administration in Transplant Patients
by: Janka Franeková, et al.
Published: (2021-01-01)
by: Janka Franeková, et al.
Published: (2021-01-01)
Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01)
by: M. Sh Khubutia, et al.
Published: (2016-01-01)
Aortic valve replacement for patient with infective endocarditis early after liver transplantation with a complete withdrawal of immunosuppressive therapy
by: S. F. Bagnenko, et al.
Published: (2017-12-01)
by: S. F. Bagnenko, et al.
Published: (2017-12-01)
Similar Items
-
Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
by: Tonghai Xing, et al.
Published: (2013-01-01) -
Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma
by: Qiang Wei, et al.
Published: (2016-07-01) -
Effectiveness of steroid-free immunosuppressive regimens after kidney transplantation: the pioneering experience of a brazilian center
by: Tainá Veras de Sandes-Freitas, et al.
Published: (2025-09-01) -
Immunosuppression and Liver Transplantation
by: Jan Lerut, et al.
Published: (2023-02-01) -
Side Effects of Immunosuppressant Drugs After Liver Transplant
by: Filippo Gabrielli, et al.
Published: (2025-02-01)
